Holen Sie sich die Stockscreener-App
1.67
0.60%
-0.01
Handel nachbörslich:
1.65
-0.02
-1.20%
Schlusskurs vom Vortag:
$1.68
Offen:
$1.67
24-Stunden-Volumen:
69,499
Relative Volume:
0.09
Marktkapitalisierung:
$2.73M
Einnahmen:
$4.79M
Nettoeinkommen (Verlust:
$-13.42M
KGV:
-0.6278
EPS:
-2.66
Netto-Cashflow:
$-10.30M
1W Leistung:
-5.11%
1M Leistung:
-51.17%
6M Leistung:
-50.66%
1J Leistung:
-83.33%
1-Tages-Spanne:
$1.61
$1.70
1-Wochen-Bereich:
$1.61
$1.91
52-Wochen-Spanne:
$1.61
$11.50
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
Firmenname
Qualigen Therapeutics Inc
Sektor
Branche
Telefon
(760) 918-9165
Adresse
2042 CORTE DEL NOGAL, CALIFORNIA
Vergleichen Sie QLGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
1.67 | 2.75M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Qualigen Therapeutics Inc Aktie (QLGN) Neueste Nachrichten
Chart based analysis of Qualigen Therapeutics Inc. trendsRate Cut & Low Risk Growth Stock Ideas - Newser
Comparing Qualigen Therapeutics Inc. in custom built stock radarsEarnings Growth Report & Risk Managed Investment Entry Signals - Newser
What MACD signals say about Qualigen Therapeutics Inc.2025 Institutional Moves & Verified Swing Trading Watchlists - Newser
What makes Qualigen Therapeutics Inc. stock price move sharplyEarnings Growth Report & High Return Stock Watch Alerts - Newser
Should you wait for a breakout in Qualigen Therapeutics Inc.Daily Market Momentum Summary and Strategy - Newser
Does Qualigen Therapeutics Inc. fit your quant trading modelBuy Strategy Review With Performance Summary - Newser
Will Qualigen Therapeutics Inc. continue its uptrendDaily Entry Opportunity Forecasting Tool - Newser
Volume spikes in Qualigen Therapeutics Inc. stock – what they meanAI Powered Stock Market Trend Forecast - Newser
Statistical indicators supporting Qualigen Therapeutics Inc.’s strengthSwing Entry Risk Mitigation with Chart Analysis - Newser
Technical signs of recovery in Qualigen Therapeutics Inc.Bull Market Summary and Recovery Outlook - Newser
Is Qualigen Therapeutics Inc. forming a bottoming baseBuy Signal Forecast With Short-Term Data - Newser
Using data filters to optimize entry into Qualigen Therapeutics Inc.Early Entry Planner for Swing Candidates - Newser
Evaluating Qualigen Therapeutics Inc. with trendline analysisFree Secure Capital Picks With Upside Potential - Newser
What MACD and RSI say about Qualigen Therapeutics Inc.Portfolio Risk Distribution Analysis Tool - Newser
Full technical analysis of Qualigen Therapeutics Inc. stockPortfolio Building Plan and Summary Guide - Newser
Is Qualigen Therapeutics Inc. showing signs of accumulationShort-Term Upside Breakout Forecast System - Newser
How Qualigen Therapeutics Inc. stock performs during market volatilityFree High Conviction Intraday Stock Signals - Newser
Momentum Screeners Rank Qualigen Therapeutics Inc. in Top 5 TodayBuy Signal Based on Chart Analysis Confirmed - metal.it
Qualigen Therapeutics Inc. Flashes Rebound Signal in Oversold ConditionWeekly Top Gainers Forecast Watchlist Released - metal.it
What catalysts could drive Qualigen Therapeutics Inc. stock higher in 2025Discover hidden gems in the stock market - Jammu Links News
What institutional investors are buying Qualigen Therapeutics Inc. stockCapitalize on market trends with confidence - Jammu Links News
How many analysts rate Qualigen Therapeutics Inc. as a “Buy”Capitalize on market trends with confidence - Jammu Links News
How does Qualigen Therapeutics Inc. generate profit in a changing economyPowerful growth strategies - Jammu Links News
How volatile is Qualigen Therapeutics Inc. stock compared to the marketAchieve breakthrough performance in the market - Jammu Links News
News impact scoring models applied to Qualigen Therapeutics Inc.Weekly Entry Signal Based Forecast Tool - newser.com
Finanzdaten der Qualigen Therapeutics Inc-Aktie (QLGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):